cTRL Therapeutics Appoints Derrell D. Porter, M.D., as Chief Executive Officer
/PRNewswire/ -- cTRL Therapeutics, a biotechnology company harnessing circulating tumor-reactive lymphocytes (cTRLs) in the blood to broaden the power and...
Source: prnewswire.com